Background. The mechanisms of immunity to Rickettsia conorii that have been elucidated in mouse models have not been evaluated in human tissues.
in protection against rickettsial infection or in the pathogenesis of MSF remain to be characterized [7] . In vitro studies have shown that intracellular killing of R. conorii within human endothelium, macrophages, and hepatocytes is mediated by either 1 or a combination of 3 mechanisms involving nitric oxide, hydrogen peroxide, and tryptophan degradation [8] . Human hepatocytes stimulated by interferon (IFN)-g, tumor necrosis factor (TNF)-a, interleukin (IL)-b, and RANTES kill intracellular rickettsiae by a nitric oxide-dependent mechanism. Human macrophages and monocytes activated by cytokines kill intracellular rickettsiae by a hydrogen peroxide-dependent mechanism and, via expression of the tryptophan-degrading enzyme indoleamine-2,3-dioxygenase (IDO), by limitation of the availability of tryptophan. It is not known (1) whether these effector molecules are produced in humans and (2) whether the production of these molecules is dependent on a particular cytokine and chemokine environment.
IFN-g and TNF-a have been associated with a favorable outcome in our in vitro and in vivo murine studies of rickettsial infection [9] . Th1 responses, characterized by the production of IFN-g (which favors not only the activation of microbicidal mechanisms of macrophages and other infected target cells but also the differentiation of B cells for production of Th1 isotype antibody) together with the activation of antigen-specific cytotoxic CD8 + T cells, appear to be protective [9, 10] . It is not known whether Th2 responses, characterized by the production of IL-4 and/or IL-10, play no role or have a detrimental effect. Also, it is not known whether immunopathological conditions play a role in human rickettsial infections. To determine the local immune and inflammatory responses at sites of rickettsial infection, we prospectively studied Portuguese patients with MSF. We examined the mRNA-expression levels of TNF-a, RANTES, IFN-g, IL-10, IDO, and inducible nitric oxide synthase (iNOS), which are critical molecules in antirickettsial immune responses [8] [9] [10] [11] [12] , in skin-biopsy samples from patients with MSF that were collected 3-14 days after onset of fever. The mRNA-expression levels of TNF-a, IFN-g, RANTES, IDO, and iNOS in these patients were significantly greater than those in the control subjects.
SUBJECTS AND METHODS

Human Subjects
Patients with a clinical diagnosis of MSF who were admitted to hospitals in Portugal were included in the study. The initial diagnosis of MSF was based on clinical signs, fever, rash, and/ or eschar, with or without myalgias, headache, leukopenia, thrombocytopenia, and elevated levels of hepatic enzymes. In some cases, data on history of tick exposure, outdoor activities, and animal contact were obtained. The diagnosis was confirmed on the basis of detection of anti-Rickettsia antibodies, by immunofluorescence assay (IFA), and/or of Rickettsia organisms or DNA in blood, by culture or polymerase chain reaction (PCR), or DNA in skin, by PCR. For each patient, epidemiological and clinical data were recorded on a standardized form.
The severity of MSF was scored on the basis of either admission to the intensive-care unit (ICU) or evidence of hepatic injury, respiratory or renal insufficiency, or hematological or neurological involvement. Hepatic injury was defined as elevated (1100 U/L) serum levels of alanine aminotransferase (ALT). Respiratory insufficiency was defined as hypoxemia (arterial Po 2 !70 mmHg), and renal insufficiency was defined as a serum level of creatinine that was у1.8 mg/dL). Neurological involvement was characterized by confusion. Hematological involvement was defined as either mild/moderate (120,000-150,000 platelets/mL) or severe (!120,000 platelets/mL) thrombocytopenia with or without anemia and/or leukopenia. Of the 23 patients with MSF, 5 were considered to represent severe cases (table 1), on the basis of either involvement of у3 organ systems or admission to the ICU (in the case of 2 patients), whereas 7 were considered to represent moderately severe cases, on the basis of involvement of 2 organ systems; the remaining 11 patients were considered to represent mild cases, on the basis of involvement of only 1 organ system.
Sample Collection
Blood samples were collected from the patients both at their initial visit to the clinic or admission to hospital (2-7 days after onset of symptoms; mean, 5 days) and at follow-up (14-21 days after onset of symptoms; mean, 15 days). Blood was centrifuged to separate serum or plasma, for IFA, and peripheral mononuclear cells (buffy coat), for culture. Samples were stored at Ϫ80ЊC until processed.
Skin-Biopsy Samples
At admission, skin punch-biopsy samples (diameter, 5 mm) were obtained from the 23 patients and 8 control subjects. Control skin-biopsy samples were obtained from discarded skin tissues from patients admitted for surgical treatment of inguinal hernia. In these latter patients, rickettsial infection was excluded by either serological analysis or PCR performed on the skin tissues. Informed consent was obtained from all subjects, and the experiments were performed with the approval of the ethical committees of the hospitals and the National Institute of Health. Before treatment, 20 skin-biopsy samples were obtained from eschars, and 3 were obtained maculopapular rashes.
Laboratory Confirmation of MSF
Serological analysis. Testing of acute and convalescent sera confirmed the diagnosis of R. conorii infection when (1) samples of acute serum contained IgM antibodies at a titer of у32 and/or IgG antibodies at a titer of у128 (on the basis of cutoff values established by the National Institute of Health for the Portuguese population) or (2) there was a 4-fold increase between the titer for acute serum and that for convalescent serum [13, 14] .
Isolation. Isolation of Rickettsia from patients' blood, as well as strain identification, were performed as described elsewhere [15] .
Detection of Rickettsia in skin-biopsy samples by PCR. DNA was extracted from the skin samples by use of a DNeasy Tissue Kit (Qiagen). PCR, nested-PCR, and rickettsial-strain characterization were performed as described elsewhere [16] .
Detection of Immune-Response Markers in Skin Samples by Real-Time Quantitative Reverse Transcriptase (RT)-PCR
Total RNA was extracted from skin-biopsy samples by an organic extraction method using the RNaqueous Kit (Ambion). Samples were treated with DNase (DNA-free; Ambion). Extracted RNA was quantified, and the ratio of the absorbance values at wavelengths 260 nm and 280 nm was used to estimate the purity of the RNA.
Quantitative real-time RT-PCR assayed the mRNA expression of RANTES, TNF-a, IFN-g, IL-10, IDO, iNOS, and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), using the iCycler iQ Multicolor Real-Time Detec- tion system (Bio-Rad) in combination with the QuantiTect Probe RT-PCR Gene Expression kit (Qiagen) The primers and probes used in the present study (Qiagen) are shown in table 2. Amplifications and the thermal-cycler parameters used followed the manufacturer's recommendations. Each sample was analyzed in duplicate, and the average was used to calculate relative mRNA expression. We used the delta-delta method (i.e., comparative C T [DC T ] method) for quantitative analysis of gene expression [17] . The results were normalized to those for GAPDH in the same sample and were expressed as copy number per 10,000 GAPDH copies.
Statistical Analysis
Data analysis was performed by use of frequency distributions and central-tendency measures. Comparison of frequencies between groups of patients was evaluated by x 2 test or Fisher's exact test. The Mann-Whitney and Kruskal-Wallis tests were used to compare distributions, allowing us to examine the relation between the mRNA levels of different cytokines and their association with the severity of MSF. Correlations between cytokines were analyzed on the basis of Spearman and Pearson's correlation coefficients, allowing us to examine the relation between the mRNA levels of different cytokines and their correlation with the severity of MSF.
was regarded as being P ! .05 statistically significant.
RESULTS
Study Population and Clinical Data
The clinical diagnosis of MSF in the 23 patients in the present study was confirmed by serological analysis and/or rickettsial isolation and/or PCR-based detection of rickettsial DNA in skin-biopsy samples (table 3); 2 of these patients (9%) were treated as outpatients, and the remaining 21 patients (91%) were admitted to the hospital, where 2 of them (9%) subsequently were transferred to the ICU. Epidemiological, clinical, and laboratory data are presented in tables 4 and 5.
The levels of aspartate aminotransferase (AST) in patients with severe MSF were significantly higher than those in patients with mild/moderate MSF (mean levels of AST were 211 U/L and 58 U/L, respectively;
). Although ALT levels in pa-P p .01 tients with severe MSF were higher than those in patients with mild/moderate MSF, the difference was not statistically significant (mean levels of ALT were 207 U/L and 82 U/L, respectively; ) P p .17 Risk factors that could potentially be associated with moderate/severe MSF included diabetes mellitus (1 patient), alcoholism (2 patients), age у65 years (8 patients), and coronary artery disease (1 patient). Also, 2 patients had HIV and hepatitis C virus (HCV) infection; both of them were receiving antiretroviral and anti-HCV therapy and had very low viral loads.
High mRNA-Expression Levels of TNF-a, IL-10, IFN-g, RANTES, IDO, and iNOS, in Skin from Patients with MSF
The expression of TNF-a mRNA in the patients with MSF was significantly higher ( ) than that in the control subjects. P ! .0007 The median TNF-a mRNA-expression in the patients with MSF was ∼10,000 copies, compared with 3300 copies in the control subjects ( figure 1A) . The mRNA-expression levels of IL-10, IFN-g, RANTES, and IDO showed similar patterns: levels in the patients with MSF were significantly higher ( ) than P ! .0001 those in the control subjects; the median copy numbers of these different cytokines' mRNA in the patients with MSF versus the healthy control subjects were as follows: IL-10, 3434 versus 287; IFN-g, 860 versus 5; RANTES, 13,736 versus 1187; and IDO, 2888 versus 43 ( figure 1B-1E ). In 17 of the patients with MSF, the mean mRNA-expression levels of iNOS were comparable to those in the control subjects (copy numbers 687 and 760, respectively) ( figure 1F) ; in the remaining 6 patients, the levels were significantly higher than those in the control subjects. Taken together, these data suggest that rickettsial infection is associated with increased expression of several immune and inflammatory mediators in the skin of patients with MSF, with a trend toward mixed type 1, proinflammatory, and anti-inflammatory responses.
Correlations between mRNA-Expression Level of TNF-a, IFN-g, and IL-10
The critical factors responsible for immunoregulation in particular infections, as well as the variation in response and outcome between different patients, are determined by the balance between pro-and anti-inflammatory mediators [18] [19] [20] [21] . To determine whether such an immunoregulatory mechanism existed in the patients in the present study, we compared the mRNA-expression levels of pro-and anti-inflammatory cytokines. We observed nonlinear relationships between the mRNAexpression levels of TNF-a and IL-10 (figure 2A), as well as between those of IFN-g and IL-10 ( figure 2B ). In 67% of the patients with MSF, a significantly ( ) positive correlation P ! .05 was detected between the р3800-copies expression level of IL-10 mRNA and an elevated level of TNF-a mRNA; in contrast, in 33% of the patients with MSF, a significantly negative correlation was observed between a high (13800 copies) level of IL-10 mRNA expression and a low level of TNF-a mRNA expression. Similarly, in 73% of the patients with MSF, the р5000-copies level of IL-10 mRNA expression correlated with elevated IFN-g mRNA expression (figure 2B), whereas an elevated (15000 copies) level of IL-10 mRNA expression correlated with down-regulation of IFN-g mRNA ( ). These P p .06 data suggest the presence of an immunoregulatory mechanism, mediated by anti-inflammatory IL-10, that can help to avoid severe tissue damage due to excess intralesional production of proinflammatory and type 1 cytokines.
Local Production of High mRNA-Expression Levels of TNF-a and IFN-g: Frequent Association with High mRNA-Expression Levels of iNOS and IDO
In the patients with MSF, a significant ( ) positive cor-P p .028 relation was observed between the level of IFN-g mRNA expression and that of iNOS mRNA, as well as between the level of IFN-g mRNA expression and that of IDO mRNA ( figure  2C and 2D ), correlations that were not observed in the control subjects (data not shown). In most of the patients with mild or severe MSF, higher levels of IFN-g mRNA expression correlated with higher levels of iNOS mRNA expression and of IDO mRNA expression. In the patients with MSF, a similarly significant ( ) positive correlation was observed be-P p .002 tween the mRNA-expression levels of TNF-a and those of iNOS and of IDO ( figure 2E and 2F ), a correlation that was not observed in the control subjects (data not shown). These data suggest that TNF-a and IFN-g play a protective role in rickettsial diseases in humans, via activation of intracellular bactericidal mechanisms.
Local Production of High Levels of TNF-a mRNA: Association with High Levels of IFN-g mRNA
In the patients with MSF, a significant ( ) positive P p .0001 correlation was observed between the level of TNF-a mRNA expression and that of IFN-g mRNA expression (figure 3A), a correlation that was not observed in the control subjects ( figure  3B ). These results suggest that TNF-a and IFN-g have potentially synergistic effects with respect to the activation of intracellular bactericidal effector mechanisms.
Comparison of mRNA-Expression Levels of TNF-a, IL-10, IFN-g, RANTES, iNOS, and IDO, in Mild, Moderate, and Severe MSF
To assess the contribution that pro-and anti-inflammatory mediators make to the development of mild and severe MSF, we examined the mRNA-expression levels of IFN-g, TNF-a, IL-10, RANTES, iNOS, and IDO in patients with mild, moderate, or severe MSF. Although the median mRNA-expression levels of IFN-g, TNF-a, IL-10, iNOS, and IDO were not statistically significantly different between patients with these 3 differing severities of illness (table 6) , our data demonstrated a trend toward expression of substantially high levels of certain biomolecules in either mild or severe MSF (table 7) : TNF-a mRNA-expression levels of у6500 copies were detected in 64%, 86%, and 100% of patients with mild, moderate, and severe MSF, respectively; in contrast, IFN-g mRNA-expression levels of у500 copies were detected in 45%, 57%, and 20% of patients with mild, moderate, and severe MSF, respectively. All patients with severe MSF had very high IDO mRNA-expression levels (у1500 copies), compared with only 45% of patients with mild MSF; in contrast, у800 copies of iNOS mRNA were expressed in 45% of patients with mild MSF, whereas similar levels were expressed in only 14% and 20% of patients with moderate and severe MSF, respectively. The level of IL-10 mRNA expression was comparable in all 3 groups of patients: levels of у3000 copies were detected in 64%, 43%, and 60% of patients with mild, moderate, and severe MSF, respectively. All of the patients with severe MSF had high RANTES mRNA-expression levels 
tumor necrosis factor (TNF)-a (A), interleukin (IL)-10 (B), interferon (IFN)-g (C), RANTES (D), indoleamine-2,3-dioxygenase (IDO) (E), and inducible nitric oxide synthase (iNOS) (F), in patients with
Mediterranean spotted fever (Cases) and in control subjects (Controls), quantified by real-time reverse-transcriptase polymerase chain reaction. Cycle threshold values for genes of interest were normalized to those for glyceraldehyde-3-phosphate dehydrogenase and were used to calculate the relative extent of mRNA expression. The tops and bottoms of the shaded boxes denote the 25th and 75th percentiles, respectively, and the horizontal line within each of the boxes denotes the median value; dots denote outliers.
(у10,000 copies), an expression level that was close to being significantly higher in patients with severe MSF than in patients with mild or moderate MSF (table 7) .
DISCUSSION
Most of our understanding of immune responses in rickettsial diseases stems from murine models of disseminated spottedfever rickettsiosis. Few studies in patients with rickettsial diseases have examined the levels of pro-and anti-inflammatory and immune mediators in the sera of such patients. However, no previous human studies directly examined either the local mediators of inflammation or the immune response at the site of infection (e.g., skin) in rickettsial diseases. The present study is, to our knowledge, the first comprehensive study of intralesional expression of cytokine and chemokine transcripts in patients with MSF. Certain patterns are evident in the study's results. First, the data revealed mixed type 1, proinflammatory, and anti-inflammatory responses, as reflected by elevated levels of mRNA expression of IFN-g, TNF-a, and IL-10 in patients with MSF. The correlation between elevated intralesional ex- pression of IFN-g mRNA, particularly in patients with mild/ moderate MSF, and the absence of rickettsiae in the blood suggests that there is an IFN-g-mediated reduction in bacterial load in these patients. Second, the data demonstrate a positive correlation between high levels of IFN-g mRNA and TNF-a mRNA and the production of enzymes involved in limiting microbial growth-enzymes such as iNOS [22] [23] [24] and IDO [8, 25] -in the patients with MSF but not in the control subjects. Both iNOS and IDO are produced by many types of innate immune cells, in response to either bacterial endotoxins or proinflammatory and Th1 cytokines such as TNF-a and IFNg [25] [26] [27] [28] [29] [30] [31] [32] . Thus, the correlation, in these patients with MSF, between elevated mRNA expression of IFN-g and TNF-a and mRNA expression of iNOS and IDO suggests that IFN-g and TNF-a play a synergistic role in the induction of iNOS and IDO.
The data in the present study show that some patients developed moderate/severe MSF in spite of significantly higher mRNA levels of dermal TNF-a and, to a lesser extent, of dermal IFN-g. On the basis of these data, we propose 2 potential mechanisms that could account for the development of severe MSF. First, the simultaneous expression of higher levels of immunosuppressive IL-10 mRNA may decrease responsiveness to IFN-g. IL-10 is associated with disease progression or with counteracting the IFN-g-and TNF-a-mediated activation of intracellular microbicidal mechanisms [29, 30] . Analysis of the serum cytokine profile in Sicilian patients with MSF has also suggested that IL-10 plays a Th1-inhibitory role [6] . In addition, Figure 3 . A, Correlation between mRNA-expression levels of tumor necrosis factor (TNF)-a and interferon (IFN)-g, in patients with Mediterranean spotted fever (MSF). In these patients, there was a significant positive ( ) correlation between the level of TNF-a mRNA ex-P p .0001 pression and that of IFN-g mRNA expression, a correlation that was not observed in the control subjects (data not shown). B, Comparison between the level of RANTES mRNA expression in patients with mild/moderate MSF and that in patients with severe MSF. The level of expression of RANTES mRNA is close ( ) to being significantly higher in patients P p .073 with severe MSF than in patients with mild/moderate MSF. The tops and bottoms of the shaded boxes denote the 25th and 75th percentiles, respectively, and the horizontal line within each of the boxes denotes the median value; dots denote outliers.
the production of Th1-promoting cytokines, such as IL-12, by peripheral blood mononuclear cells from patients with MSF was enhanced in vitro by the addition of either recombinant IFN-g or anti-IL-10 monoclonal antibodies [33] . Second, unbalanced pro-and anti-inflammatory cytokine responses with higher levels of TNF-a were observed in patients with severe MSF. This immunopathological condition represents disease manifestations that are caused by the immune system while the latter is attempting to control infection. The present study does not provide direct evidence for immunopathological condition in rickettsial disease. However, previous immunohistochemical and histopathological analyses of eschars either from fatal cases of Rocky Mountain spotted fever (RMSF) or from patients with MSF suggest the possibility that immune-mediated pathological mechanisms are present in MSF [7, 34, 35] . This hypothesis is based on 3 main features: (1) the eschars from patients with RMSF contained a massive quantity of rickettsiae in the endothelium and vascular smooth-muscle cells of the blood vessels, whereas very few organisms were present in the eschars from patients with MSF; (2) abundant lymphohistiocytic infiltrates, mainly T lymphocytes, were observed in lesions from patients with MSF; and (3), compared with the cutaneous necrosis in eschars from patients with RMSF and the association between such necrosis and occlusive thrombosis, the eschar lesion in patients with MSF was associated with dermal edema, edema of the vascular wall, and endothelial swelling [7, 34, 35] . Thus, the occurrence of moderate/severe vascular injury and cutaneous necrosis in MSF, in the absence of occlusive thrombosis and overwhelming infection but in the presence of abundant lymphohistiocytic infiltration, suggests the possibility of an immunopathological mechanism of the lesion. Moreover, the absence of rickettsiae in the blood of patients with severe MSF (table 3) further supports the hypothesis that severe MSF could be due to an immunopathological condition rather than to an overwhelming infection. On the basis of the aforementioned data, we postulate that balanced pro-and anti-inflammatory cytokines mediate protective type 1 immunity against Rickettsia while avoiding an immunopathological condition.
In the present study, we have also analyzed the mRNA-expression levels of IFN-g, TNF-a, iNOS, IDO, RANTES, and IL-10 in 3 groups of patients-those with mild, moderate, or severe MSF. The data do not show statistically significant differences, in median levels of expression of these biomolecules, between these 3 groups of patients; however, this could be due to (1) the multifunctionality of many biomolecules, (2) widespread interactions between them, differences in the timing of when samples were obtained, and (3) the fact that local immune responses in the skin of patients with systemic rickettsial diseases may not exactly reflect the severity of overall illness. Despite these confounding factors, certain patterns are evident. First, IFN-g is critical for protection against severe MSF, and that protection is dependent on expression of iNOS mRNA (table 7) . The data in the present study are consistent with the protective role played by IFN-g in animal models of SFG rickettsiosis [10, 36] ; however, they are in disagreement with the results of a previous study [5] , which showed that IFN-g was absent in acute and convalescent plasma samples from patients with African tick-bite fever (ATBF), an SFG rickettsiosis caused by R. africae. These discordant results could be due to the possibility that cutaneous, rather than systemic, production of IFN-g is the better indicator of protection against Rickettsia. Second, in the present study, high (у6500 copies) levels of TNF-a mRNA were detected in only 64% of patients with mild MSF, whereas they were detected in 100% of patients with severe MSF. These data suggest that TNF-a plays a dual role, being involved in both protective antirickettsial immunity and the pathogenesis of severe MSF. Supporting this conclusion are the results of a previous study [6] , which has demonstrated high plasma levels of TNF-a in acute serum from patients with ATBF, levels that, on follow-up, subsequently decreased to levels that were comparable to those in control subjects. Third, the present study revealed expression of high levels of RANTES mRNA in all patients with MSF, in contrast to what was observed in the control subjects, with significantly higher expression in patients with severe MSF than in those with mild/ moderate MSF ( figure 3B ). RANTES is a chemokine that mediates the trafficking and homing of several lymphoid and myeloid cells, such as T cells, monocytes, and dendritic cells, toward the site of infection [37] . The expression of RANTES mRNA in the skin of patients with MSF could therefore explain the presence of prominent perivascular cellular infiltration in SFG rickettsiosis [7, 10, 34, 38] . The data in the present study also suggest that, like TNF-a, RANTES plays a dual role, being involved in both antirickettsial immunity and the pathogenesis of severe MSF. The protective role of RANTES could be due to RANTES-mediated chemotaxis of IFN-g-producing CD4 Th1 lymphocytes toward the cutaneous site of infection. This conclusion is supported both by histological observation of an abundance of CD4 T cells in eschars from patients with MSF and by studies suggesting that RANTES plays a microbicidal role in certain viral and bacterial infections, including rickettsioses [8, 39] . On the other hand, the pathological role of RANTES could be attributed to expression of a very high level of the latter, which could substantially increase T cell infiltration at the site of infection, with subsequent sustained production of excessive amounts of proinflammatory cytokines. The latter can lead to indirect damage to endothelial cells, leading to the vascular dysregulation and leakage observed in SFG rickettsial infections. In support of this hypothesis, it has been shown that a high concentration of RANTES induces the activation of T cells in a manner that is usually followed by diverse effects, including substantial T cell proliferation or apoptosis and the release of proinflammatory cytokines [40] . A closer examination of the production of each of these mediators in a timecourse study, as well as identification of the cellular source of these mediators in large groups of patients with MSF of different degrees of severity, is warranted, to attain a better understanding of MSF in humans.
